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Abstract 31 
Study question: Is implantation failure following ART associated with a perturbed decidual 32 
response in endometrial stromal cells (EnSCs)?  33 
Summary answer: Dynamic changes in the secretome of decidualizing EnSCs underpin the 34 
transition of a hostile to a supportive endometrial microenvironment for embryo 35 
implantation; perturbation in this transitional pathway prior to ART is associated with 36 
implantation failure.  37 
What is known already: Implantation is the rate-limiting step in ART, although the 38 
contribution of an aberrant endometrial microenvironment in IVF failure remains ill defined.  39 
Study design, size, duration: In vitro characterisation of the temporal changes in the 40 
decidual response of primary EnSCs isolated prior to a successful or failed ART cycle. An 41 
analysis of embryo responses to secreted cues from undifferentiated and decidualizing EnSCs 42 
was performed. The primary clinical outcome of the study was a positive urinary pregnancy 43 
test 14 days after embryo transfer. 44 
Participants/materials, setting, methods: Primary EnSCs were isolated from endometrial 45 
biopsies obtained prior to IVF treatment and cryopreserved. EnSCs from 10 pregnant and 10 46 
non-pregnant patients were then thawed, expanded in culture, subjected to clonogenic assays, 47 
and decidualized for either 2 or 8 days. Transcript levels of decidual marker gene [prolactin 48 
(PRL), insulin-like growth factor binding protein 1 (IGFBP1) and 11β-hydroxysteroid 49 
dehydrogenase (HSD11B1)] were analysed using real-time quantitative PCR and temporal 50 
secretome changes of 45 cytokines, chemokines and growth factors were measured by 51 
multiplex suspension bead immunoassay. The impact of the EnSC secretome on human 52 
blastocyst development was scored morphologically; and embryo secretions in response to 53 
EnSC cues analyzed by multiplex suspension bead immunoassay. 54 
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Main results and the role of chance: Clonogenicity and induction of decidual marker genes 55 
were comparable between EnSC cultures from pregnant and non-pregnant group groups (P > 56 
0.05). Analysis of 23 secreted factors revealed that successful implantation was associated 57 
with co-ordinated secretome changes in decidualizing EnSCs, which were most pronounced 58 
on day 2 of differentiation: 17 differentially secreted proteins on day 2 of decidualization 59 
relative to undifferentiated (day 0) EnSCs (P < 0.05); 11 differentially secreted proteins on 60 
day 8 relative to day 2 (P < 0.05); and 8 differentially secreted proteins on day 8 relative to 61 
day 0 (P < 0.05). By contrast, failed implantation was associated with a disordered secretome 62 
response. Blastocyst development was compromised when cultured for 24 hours in medium 63 
conditioned by undifferentiated EnSCs when compared to decidualizing EnSCs. Analysis of 64 
the embryo microdroplets revealed that human blastocysts mount a secretory cytokine 65 
response to soluble decidual factors produced during the early (day 2) but not late phase (day 66 
8) of differentiation. The embryo responses to secreted factors from decidualizing EnSCs 67 
were comparable between the pregnant and non-pregnant group (P > 0.05). 68 
Large scale data: not applicable. 69 
Limitations, reasons for caution: Although this study uses primary EnSCs and human 70 
embryos, caution is warranted when extrapolating the results to the in vivo situation because 71 
of the correlative nature of the study and limited sample size.  72 
Wider implications of the findings: Our finding raises the prospect that endometrial 73 
analysis prior to ART could minimise the risk of treatment failure. 74 
Study funding and competing interest(s): This work was supported by funds from the 75 
Biomedical Research Unit in Reproductive Health, a joint initiative of the University 76 
Hospitals Coventry & Warwickshire NHS Trust and Warwick Medical School, the University 77 
of Nottingham and Nurture Fertility, and the National Medical Research Council, Singapore 78 
(NMRC/BNIG14NOV023). The authors have declared that no conflict of interest exists. 79 
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Introduction 82 
Implantation is the rate-limiting step in ART. Clinically, failed implantation is defined by the 83 
lack of detectable hCG levels in either serum or urine 14 days after intrauterine transfer of 84 
one or more embryos. By default, failed implantation is a retrospective diagnosis, rendering it 85 
difficult, if not impossible, to discern if caused by a hostile endometrium, impaired embryo 86 
quality, or an iatrogenic event. Nevertheless, genome-wide expression studies have identified 87 
endometrial signature genes that are predictive of recurrent implantation failure (RIF), 88 
defined as the absence of pregnancy following serial transfers of high quality embryos (Koler 89 
et al., 2009, Koot et al., 2016). Interestingly, these studies have also challenged the prevailing 90 
concept that implantation failure merely reflects a lack of expression of receptivity genes 91 
during the window of implantation (Diaz-Gimeno et al., 2011). Instead, the gene signatures 92 
associated with RIF point towards more fundamental defects pertaining to cell cycle 93 
regulation, cell motility, epithelial-mesenchymal transition (EMT), and signalling pathways 94 
involved in stem cell maintenance (e.g. WNT and Notch) (Koler et al., 2009, Koot et al., 95 
2016).   96 
 97 
Endometrial stromal cells (EnSCs) play a critical role in the implantation process, not only by 98 
relaying hormonal signals to the overlying surface epithelium (Chen et al., 2013, Cooke et 99 
al., 1997, Li et al., 2011), but also by controlling the influx and function of various immune 100 
cells, including uterine natural killer cells (Collins et al., 2009, Gellersen and Brosens, 2014, 101 
Nancy et al., 2012). Upon invasion, the implanting embryo is rapidly surrounded and 102 
encapsulated by migrating decidualizing stromal cells. As the differentiation process unfolds, 103 
gap and tight junctions form between decidualizing cells. Consequently, the conceptus 104 
becomes anchored in the endometrium and forms a matrix that enables co-ordinated 105 
trophoblast invasion (Gellersen and Brosens, 2014, Wang et al., 2004, Weimar et al., 2013). 106 
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Growing evidence indicates that decidual cells are exquisitely responsive to embryonic 107 
signals and play a critical role in embryo biosensoring and selection (Brosens et al., 2014a, 108 
Macklon and Brosens, 2014, Teklenburg et al., 2010). On the other hand, decidualization 109 
transforms EnSCs into secretory cells that determine the embryonic microenvironment upon 110 
breaching of the luminal epithelium. Whether or not failed implantation can be attributed to 111 
an altered endometrial microenvironment that impacts directly on embryo development and 112 
survival is not known.  113 
 114 
Decidualization of the human endometrium is not dependent on embryo implantation but is 115 
initiated during the mid-luteal phase of each cycle in response to the postovulatory rise in 116 
progesterone and increasing endometrial cAMP levels. Consequently, decidualization is a 117 
reiterative process, linked to cyclic activation of mesenchymal stem-like cells (MSCs) and 118 
subsequent differentiation into mature stromal cells in regenerating endometrium (Gellersen 119 
and Brosens, 2014, Lucas et al., 2016). The endometrium harbors abundant MSCs that are 120 
multipotent, immuno-privileged, and highly regenerative (Cervello et al., 2011, Gargett et al., 121 
2012, Gargett et al., 2016). Functional repair of the endometrium requires activation of 122 
poised progenitor cells, induction of transit-amplifying cells and differentiation of mature 123 
progeny, which collectively determine the tissue response to deciduogenic and embryonic 124 
cues. The mechanisms that control this regenerative pathway and ensure homeostatic 125 
balancing of the different stromal cell populations are poorly understood. Arguably, 126 
disruption of this process will give rise to dysfunctional EnSCs. Studies on primary EnSC 127 
cultures have provided ample evidence that programming defects are linked to reproductive 128 
failure. For example, endometriosis is associated with progesterone resistance, defined by the 129 
refractoriness of cultured EnSCs to deciduogenic cues (Aghajanova et al., 2010a, Aghajanova 130 
et al., 2010b, Al-Sabbagh et al., 2012, Klemmt et al., 2006, Sherwin et al., 2010, Velarde et 131 
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al., 2009). By contrast, purified EnSCs from women with a history of recurrent miscarriage 132 
mount a prolonged and highly disordered pro-inflammatory response upon treatment with 133 
deciduogenic stimuli (Lucas et al., 2016, Macklon and Brosens, 2014, Salker et al., 2011, 134 
Salker et al., 2012).  135 
 136 
In this study, we examined the clonogenicity, decidual response and secretome changes in 137 
cultured EnSCs purified from mid-luteal biopsies obtained in the cycle prior to ART. We 138 
demonstrate that successful implantation is associated with coordinated temporal changes in 139 
the secretome of differentiating EnSCs that transform a hostile maternal microenvironment 140 
into an optimal milieu for implantation. We further show an association between a disordered 141 
EnSC secretome response and sporadic failed implantation following ART.  142 
 143 
Materials and Methods 144 
Study design and participants 145 
The endometrial samples used in this study were collected as part of an ongoing trial aimed at 146 
assessing the effect of endometrial biopsy prior to ART, including IVF, ICSI, and frozen 147 
embryo replacement (FER). This trial was conducted at the Nottingham University Research 148 
and Treatment Unit in Reproduction (Nurture), Nottingham, UK (trial registration number 149 
NCT01882842). Subsequent sample analysis was carried out at the Clinical Science Research 150 
Laboratories, University of Warwick, Coventry, UK, and the Department of Reproductive 151 
Medicine, KK Women’s and Children’s Hospital, Singapore. The NHS (National Health 152 
Service) National Research Ethics Service approved this study (13/EM/0277). None of the 153 
participating subjects were on hormonal treatment within 3 months prior to the treatment 154 
cycle. Major uterine anomalies and uterine instrumentation within 3 months prior to 155 
endometrial biopsy precluded inclusion in the study. Samples were selected based on the 156 
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outcome of ART: positive or negative urine hCG 14 days after embryo transfer. No other 157 
factors were taken into consideration. Written informed consent was obtained from all 158 
participants in accordance with the guidelines in The Declaration of Helsinki 2000 and all 159 
experiments were performed in accordance with relevant guidelines and regulations. Patient 160 
demographics and treatment details are summarized in Supplementary Table S1.  161 
 162 
Endometrial biopsy and sample preparation 163 
A home urinary ovulation kit was given to each participant with instructions to test morning 164 
urine from day 8 of their menstrual cycle immediately prior to the treatment cycle. 165 
Endometrial biopsy was performed 7 to 9 days after the LH surge. All participants were 166 
advised to use barrier methods of contraception or abstain from intercourse during the biopsy 167 
cycle.  168 
Prior to biopsy, a urinary pregnancy test was carried out. An endometrial biopsy was then 169 
obtained using a Pipelle endometrial sampler (CCD, Paris). Briefly, the device was 170 
introduced into the uterus until resistance from the fundus was felt. The piston was 171 
withdrawn to generate negative pressure and the device rotated through 360o as it was 172 
gradually withdrawn. Biopsies were transferred to the laboratory in DMEM/F12 medium 173 
supplemented with 10% dextran-coated charcoal-treated fetal bovine serum (DCC-FBS) 174 
(Thermo Fisher Scientific, Loughborough, UK) and 1% antibiotic-antimycotic solution 175 
(Invitrogen, Paisley, UK). The tissues were washed twice in DMEM/F12, finely minced, and 176 
enzymatically digested with collagenase type 1A (134 U/ml; Sigma-Aldrich, Gillingham, 177 
UK) and deoxyribonuclease type 1 (156 U/ml; Roche, Burgess Hill, UK) for 1 h at 37 oC. 178 
After centrifugation at 400  g for 4 min, the pellet, consisting of dispersed endometrial cells, 179 
was re-suspended in FBS containing 10% dimethyl sulfoxide (DMSO) (Sigma-Aldrich, 180 
Gillingham, UK), frozen at an approximate rate of -1°C / min, and stored in liquid nitrogen.  181 
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 182 
ART protocols 183 
In the cycle after the endometrial biopsy, participants underwent IVF/ICSI treatment using 184 
standard stimulation protocols. In brief, during a long agonist protocol, pituitary down-185 
regulation with the GnRH agonist, buserelin (Sanofi, Guildford, UK) or nafarelin (Pfeizer, 186 
Puurs, Belgium), was commenced 7 days prior to the date of the next expected menstrual 187 
bleed. Following a withdrawal bleed, a transvaginal ultrasound scan was performed to 188 
confirm downregulation using the following criteria: quiescent ovaries with follicles < 10 189 
mm diameter, endometrium ≤ 5mm in thickness and serum estradiol level < 200 pmol/L. 190 
Ovarian stimulation was achieved with HMG (Menopur; Ferring, West Drayton, UK) or 191 
recombinant FSH- follitropin α (Gonal-F, Merck Serono, Feltham UK) administered by s.c. 192 
injection at a daily dose tailored to the individual according to markers of ovarian reserve.  193 
From day 6 of stimulation, subjects were monitored for their ovarian response using 194 
ultrasound and serum estradiol levels. In case of a short protocol, women started GnRH 195 
agonist (Sanofi) on day 2 of the menstrual period and stimulation was on day 3 of her period. 196 
When a short antagonist protocol was used, stimulating medications (Menpur or Gonal-F) 197 
were commenced on day 2 of her period. GnRH antagonist, cetrorelix (Cetrotide, Merck 198 
Serono) was commenced when a lead follicle began to develop. Once women met the criteria 199 
for oocyte retrieval (≥3 leading follicles of ≥17 mm in diameter), 250 µg of 200 
choriogonadotrophin α, (Ovitrelle, Merck Serono), was administered subcutaneously to 201 
trigger final follicular maturation. Transvaginal ultrasound-guided oocyte retrieval was 202 
performed 36 h later. In all our patients, one or two embryos were transferred on day 5. An 203 
elective single embryo policy applied to women under the age of 37 years undergoing a first 204 
treatment cycle. Women not meeting these criteria were eligible to have double embryo 205 
transfer. Micronized progesterone (Cyclogest, 400 mg twice daily; Actavis, Barnstaple, UK) 206 
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administered vaginally was used as luteal support from the day of transfer until the time of 207 
the pregnancy test and continued to the 10th week of pregnancy in those with positive tests. In 208 
the natural FER cycle, ultrasound examinations were carried out every 2 to 3 days from day 6 209 
of the cycle onwards. When a dominant follicle (≥ 18 mm) was identified, the LH surge was 210 
monitored using a home urinary LH detection kits. Embryo transfer was carried out 5 days 211 
after the LH surge. Luteal support was not administered. 212 
A home urinary pregnancy test was performed 14 days after the embryo transfer. If positive, 213 
a transvaginal scan was performed at 6-8 weeks gestation to confirm viability. The main 214 
clinical outcome of the study was a positive biochemical pregnancy per woman, defined as a 215 
positive urinary pregnancy test 14 days after embryo transfer. Secondary outcomes included a 216 
clinical pregnancy defined as evidence of a viable fetus on a transvaginal scan performed at 217 
6-8 weeks gestation, and live birth (delivery of a viable fetus after the 24th completed week of 218 
gestation).  219 
 220 
Primary EnSC culture 221 
Once the outcome of the IVF treatment was known, frozen endometrial cell suspensions from 222 
20 patients were thawed and expanded in DMEM/F12 containing 10% DCC-FBS, 1% L-223 
glutamine (Thermo Fisher Scientific) , 1% antibiotic-antimycotic solution, insulin (2 µg/mL; 224 
Sigma-Aldrich) and estradiol (1nM; Sigma-Aldrich). At passage 2, cells were plated in two 225 
6-well plates. When confluent, the cultures were either maintained in phenol red-free 226 
DMEM/F12 containing 2% DCC-FBS and 1% antibiotic-antimycotic solution (Thermo 227 
Fisher Scientific) or decidualized in the same medium supplemented with 0.5 mM 8-228 
bromoadenosine cAMP (8-bromo-cAMP; Sigma-Aldrich) and 1 µM medroxyprogesterone 229 
acetate (MPA; Sigma-Aldrich). The media was changed every 48 h. EnSCs remained either 230 
untreated for 8 days or decidualized in a reversed time-course, meaning that the medium on 231 
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all cultures was switched from high to low serum (10% to 2% DCC-FBS) on day 0, 232 
decidualization was then triggered at different time-points, and all cultures were harvested on 233 
day 8. This design negates potential artefacts induced by the switch of high to low serum 234 
culture conditions. Total RNA was extracted and culture supernatants snap-frozen and stored 235 
at -80 oC until further analysis.  236 
 237 
In vitro colony-forming assay 238 
Colony-forming assays were performed at passage 1 as previously described (Murakami et 239 
al. , 2013, Murakami et al. , 2014). Briefly, EnSCs were seeded at a clonal density of 30 240 
cells/cm2 on 60 mm fibronectin-coated culture dishes and cultured in DMEM/F12 241 
supplemented with basic fibroblast growth factor (10 ng / mL; Merck Millipore, Watford, 242 
UK). A partial medium change was performed on day 7, 10, and 12 of culture. Microscopic 243 
examination of colonies was performed periodically to confirm that the colonies arose from 244 
single cells. The culture was continued for 15 days and stained with haematoxylin. Colonies 245 
consisting of more than 50 cells were counted and cloning efficiency was calculated using the 246 
formula: CE (%) = (number of colonies / number of seeded cells)  100. 247 
 248 
Real-time Quantitative (RTq)-PCR 249 
Total RNA was extracted from cultured EnSCs using RNA STAT-60 after decidualization 250 
using cAMP and MPA. Total RNA (1 µg) was DNase (Sigma-Aldrich) treated and reverse 251 
transcribed using a QuantiTect Reverse Transcription Kit (Sigma-Aldrich). The resulting 252 
cDNA was used for RT-qPCR analysis. Power SYBR Green PCR Master Mix was used for 253 
template quantification on a 7500 Real-time PCR System (Applied Biosystems, Paisley, UK). 254 
The mRNA expression levels were calculated using the efficiency corrected ΔCT method and 255 
expressed in arbitrary units. The expression levels were normalized against the levels of 256 
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RPL19, coding for ribosomal protein L19,  to nullify the variances in input cDNA. The 257 
measurements were made in triplicate. Amplification specificity of the primers was 258 
confirmed by melting curve analysis and agarose gel electrophoresis. Gene-specific primers 259 
were designed using Primer 3 software: prolactin (PRL) sense 5’-AAG CTG TAG AGA TTG 260 
AGG AGC AAA C-3’, PRL antisense 5’-TCA GGA TGA ACC TGG CTG ACT A-3’; 261 
insulin-like growth factor binding protein 1 (IGFBP1) sense 5’-CGA AGG CTC TCC ATG 262 
TCA CCA-3’, IGFBP1 antisense 5’-TGT CTC CTG TGC CTT GGC TAA AC-3’; 11β-263 
hydroxysteroid dehydrogenase 1 (HSD11B1) sense 5′-AGC AAG TTT GCT TTG GAT GG-264 
3′, HSD11B1 antisense 5′-AGA GCT CCC CCT TTG ATG AT-3′; L19 sense 5’-GCG GAA 265 
GGG TAC AGC CAT-3’, L19 antisense 5’-GCA GCC GGC GCA AA-3’. 266 
 267 
Human embryo culture 268 
The ethics committee of the Institutional Review Board of the University Hospital (UZ 269 
Brussel, Vrije Universiteit Brussel) and the Belgian Federal Ethical Committee for Scientific 270 
Research on Human Embryos approved this study and reviewed and approved the informed 271 
consent form. All experiments were performed in accordance with relevant guidelines and 272 
regulations. Vitrified day 5 blastocysts, which became available for research with written 273 
informed consent and after the legally determined storage period of 5 years, were warmed 274 
using the Vitrification Thaw Kit (Vit Kit-Thaw; Irvine Scientific, Santa Ana, CA, USA) and 275 
left to recover for 3 hours before morphological scoring by an experienced independent 276 
clinical embryologist (according to Gardner and Schoolcraft criteria) (Supplementary Table 277 
S2) (Gardner and Schoolcraft, 1999, Gardner DK, 1999). For assisted hatching, the zona 278 
pellucida was removed by pronase treatment (1 mg/ml; Sigma) for 10 min at 37°C. The 279 
resulting zona-free blastocysts were washed 3 times in human tubal fluid (HTF) HEPES (IVF 280 
Basics) medium containing albumin (CAF-DCF, Brussels, Belgium). Blastocysts were left to 281 
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recover for 3 hours after pronase treatment and scored again on morphology (data not 282 
shown). Good quality, late day 5 blastocyts were allocated randomly to pooled culture 283 
supernatant from undifferentiated EnSCs and cells decidualized for 2 or 8 days. The 284 
blastocysts were incubated undisturbed for 24 hours at 37°C in 5% carbon dioxide and 6 % 285 
oxygen. Day 6 blastocysts were morphologically evaluated and growth rates (0, 1 or 2) 286 
determined, reflecting the degree of development based on expansion and morphology scores 287 
of inner cell mass (ICM) and trophectoderm (TE). A growth rate of ‘0’ denotes that the 288 
embryo was degraded or failed to develop further; ‘1’ indicates moderately or significantly 289 
expanded embryo with a “C”-score for the TE and/or ICM; and significantly expanded 290 
embryos with ≥ “B”-score for the TE and/or ICM were scored ‘2’ (Supplementary Table S2). 291 
The microdroplets were stored individually at -80°C for multiplex secretome analysis. 292 
 293 
Secretome analysis 294 
Conditioned media collected from decidualized and undifferentiated EnSC cultures as well as 295 
embryo droplets were randomized and assayed in duplicate for 45 cytokines, chemokines and 296 
growth factors (listed in Supplementary Table S3) using a multiplex suspension bead 297 
immunoassay (Ebioscience, Singapore), according to the manufacturer’s protocol and as 298 
described previously (Murakami et al., 2014), but with some modifications. Briefly, 50 μL of 299 
conditioned media was mixed with 50 μL of antibody-conjugated, magnetic beads in a 96 300 
DropArray plate (Curiox Biosystems, Singapore) and rotated at 450 rpm on a plate shaker  301 
for 120 min at 25°C while protected from light. Beads were internally dyed with different 302 
concentrations of two spectrally distinct fluorophores and covalently conjugated to antibodies 303 
against the 45 cytokines, chemokines and growth factors (Fulton et al. , 1997). The plate was 304 
washed three times with wash buffer (PBS, 0.05% Tween-20) on the LT210 Washing Station 305 
(Curiox, Singapore) before adding 25 μL of secondary antibody and rotating at 450 rpm for 306 
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30 min at 25°C protected from light. Subsequently, the plate was washed three times with 307 
wash buffer, and 10 μL of streptavidin-phycoerythrin added and rotated at 450 rpm for 30 308 
min at 25°C protected from light. The plate was again washed three times with wash buffer; 309 
60 μL of reading buffer was then added and the samples read using the Bio-Plex Luminex 310 
200 (BioRad). The beads are classified by the red classification laser (635 nm) into its distinct 311 
sets, while a green reporter laser (532 nm) excites the phycoerythrin, a fluorescent reporter 312 
tag bound to the detection antibody. Quantitation of the 45 analytes in each sample was then 313 
be determined by extrapolation to a 6-point standard curve, as the amount of fluorescence 314 
detected by the reporter laser is proportional to the amount of target present in the sample. 315 
Data analysis of experimental data was carried out using five-parameter logistic regression 316 
modeling (Gottschalk and Dunn, 2005).  Calibrations and validations were performed prior to 317 
runs and on a monthly basis, respectively. Twenty-two factors with measurements missing 318 
from >50% of samples were excluded (Supplementary Table S3).  319 
 320 
 321 
 322 
Statistical analysis 323 
GraphPad Prism 6 (GraphPad Software Inc. California, USA) was used for statistical 324 
analyses. Data were checked for normal distribution using the Kolmogorov-Smirnov test. 325 
Unpaired or paired Student’s t-test was performed, as appropriate, to determine statistical 326 
significance between groups for normally distributed data. Mann-Whitney U test was used 327 
for non-normally distributed data. For comparing three or more groups, the data were 328 
analysed using one-way ANOVA, followed by the Student’s t-test with Bonferroni 329 
adjustment for pairwise comparisons. P < 0.05 was considered significant. Hierarchical 330 
clustering using Euclidean distance (MeV version 4.9.0) was performed on the cytokine 331 
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profiles after the normalization of significantly differential factors by first centring the data to 332 
the median and scaling it by division with the SD. Secretome data were further analysed by 333 
partial least squares regression (PLSR) modelling (Unscrambler X version 10.1) after the 334 
normalization of data by first centering the data to the median and scaling it by division with 335 
the SD. Full cross-validation was applied in PLSR to increase model performance and for the 336 
calculation of coefficient regression values. The Chi-square test was used to determine 337 
differences in embryo growth rates.  338 
 339 
Results 340 
 341 
Successful versus failed implantation: demographic and treatment variables 342 
Twenty women were enrolled in this study; 18 of Caucasian origin, 1 Indian and 1 mixed 343 
race. None of the women were smokers. Following IVF (n = 9), ICSI (n = 10) or FET (n = 1) 344 
in a natural cycle, 10 subjects had a positive pregnancy test, indicating that embryo 345 
implantation had occurred. Nine women, including two twin pregnancies, had live births. One 346 
woman suffered a pregnancy loss at 6 weeks gestation. The failed implantation group 347 
consisted of 10 subjects. As shown in Supplementary Table S1, there were no significant 348 
differences (P > 0.05) in patient characteristics, reproductive history, ovarian reserve, 349 
treatment characteristics or embryo number and quality, as assessed by standard 350 
morphological criteria, between the pregnant and non-pregnant groups. The median time 351 
between the biopsy and embryo transfer in the pregnant group was 33 days (range: 30 -36 352 
days) and 35 days (range: 32 - 40) days in the non-pregnant group (P > 0.05).  353 
 354 
Colony-forming unit-fibroblast (CFU-F) activity  355 
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To assess the CFU-F activity of EnSCs, frozen endometrial cell suspensions were thawed, 356 
expanded in T25 flasks following differential plating, and subjected to colony-forming assays 357 
at passage 1 (Figure 1). The average endometrial CFU-F activity (mean ± SEM) was 8.1 ± 358 
1.3% and 6.3 ± 1.4% in the pregnant and non-pregnant group, respectively (P > 0.05). 359 
Notably, endometrial CFU-F activity was  1% in 3 women who suffered failed implantation, 360 
indicating relative MSC deficiency (Figure 1). 361 
 362 
Responsiveness of EnSCs to deciduogenic cues  363 
For differentiation experiments, EnSCs were plated in 6-well plates, grown to confluency, 364 
and then treated or not with 8-br-cAMP and MPA for 2 or 8 days.  The median time in 365 
culture prior to the decidualization experiments was 22.5 days (range: 14 - 27 days) and 21 366 
days (range: 12 - 40 days) in the pregnant and non-pregnant group, respectively (P > 0.05). 367 
The expression of three highly sensitive decidual marker genes, PRL, IGFBP1 and 368 
HSD11B1, was determined at each time-point by RT-qPCR. As shown in Figure 2, 369 
decidualization elicited multiple-log increases in the expression of all three marker genes; but 370 
the level of induction varied greatly between cultures in both the pregnant and non-pregnant 371 
group. Furthermore, there was no significant difference (P > 0.05) in the expression of these 372 
decidual marker genes between the two clinical groups at any of the time-points. In addition, 373 
the induction of decidual marker genes was not distinct in the three cultures exhibiting 374 
relative MSC deficiency (Figure 2). 375 
 376 
An aberrant EnSC secretome is associated with subsequent failed implantation 377 
While the expression of many decidual genes, including PRL, IGFBP1 and HSD11B1, 378 
increases exponentially as the differentiation process unfolds, a host of cytokines and 379 
immunomodulators are secreted in a bi-phasic manner, characterized by a rapid rise in 380 
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response to a deciduogenic signal followed by a gradual decline (Salker et al., 2012). We 381 
used a multiplex suspension bead immunoassay to measure the secretion of 45 cytokines and 382 
immunomodulators in undifferentiated and decidualizing cultures. Out of the 23 factors 383 
detectable in a majority of samples, 19 were differentially secreted upon decidualization of 384 
cultures for either 2 or 8 days in the pregnant group. The bifurcation in the dendrogram 385 
following hierarchical clustering of regulated cytokines demonstrate that the decidual 386 
secretome profile is more divergent on day 2 of differentiation when compared to day 8 or 387 
day 0 (Figure 3A). In the pregnant group, differentially secreted factors between 388 
undifferentiated cells (day 0) and cells decidualized for 8 days (day 8) included interleukin 389 
(IL)-13, IL-6, chemokine (C-X-C motif) ligand 1 (CXCL1), and CXCL8 (IL-8). 390 
The secretome profiles of EnSC cultures from the non-pregnant group were qualitatively 391 
different and disordered, illustrated by the lack of bifurcation in the dendrogram (Figure 3B). 392 
Hierarchical clustering of regulated cytokines showed a disordered pattern with both 393 
undifferentiated (day 0) and day 8 secretome profiles aligning with day 2 samples. When 394 
compared to cultures from the pregnant group, six factors [leukemia inhibitory factor (LIF), 395 
IL-6, vascular endothelial growth factor (VEGF)-A, VEGF-D, brain-derived neurotrophic 396 
factor (BDNF), and CXCL12] were no longer differentially secreted in cultures associated 397 
with ART failure. 398 
Next, we used PLSR analysis to evaluate the temporal multivariate differences in the 399 
secretome profiles associated with successful or failed implantation. As shown in Figure 4, 400 
the secretome profiles were less divergent in cultures from the pregnant compared to the non-401 
pregnant group, at least in undifferentiated cells and cells decidualized for 8 days. The PLSR 402 
model indicated that the inherent secretome differences associated with ART failure were 403 
most pronounced in undifferentiated EnSCs. Decidual transformation of the cultures led to a 404 
partial convergence of secretome profiles in the clinical groups. Notably, the three most 405 
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divergent cultures on both day 0 and day 8 in the failed implantation group corresponded to 406 
the cultures with the lowest CFU-F activities (Figure 1).  407 
Regression coefficient values were used to identify factors that are most closely associated 408 
with successful implantation. C-C motif chemokine 3 (CCL3), also known as macrophage 409 
inflammatory protein 1α (MIP1α), exhibited the highest regression coefficient value in 410 
undifferentiated cultures, indicating a positive association with implantation (Supplementary 411 
Figure S1). Congruent with the PLSR plots (Figure 4), the strength of this association 412 
diminished upon decidual transformation of EnSCs (Supplementary Figure S2). A 413 
combination of weakly associated factors was required to generate an association between 414 
implantation and secreted factors in decidualizing cells (Supplementary Figure S2). For 415 
example, a combination of a positive factor (IL-6) and several negative factors [CCL11, 416 
CCL5, IL-18, epidermal growth factor (EGF) and VEGF-D], all with a regression coefficient 417 
less than a magnitude of 0.2, is associated with successful implantation in cultures 418 
decidualized for 8 days.  419 
 420 
Impact of the EnSC secretome on human blastocyst development 421 
To examine if and how temporal changes in decidualizing EnSC secretome impact on 422 
embryo development, vitrified day 5 human blastocysts were warmed and scored on 423 
morphology (Supplementary Table S2). Late day 5 embryos were subjected to assisted 424 
hatching and then cultured for 24 hours in 40 µl microdroplets of culture supernatant of 425 
undifferentiated EnSCs and cells first decidualized for either 2 or 8 days. Separate pools of 426 
culture supernatants were established from the pregnant and non-pregnant groups. The 427 
morphology of the embryos was rescored following 24 hours of incubation and the 428 
development of the embryos was evaluated and growth rates (0, 1 or 2) determined. 429 
Increasing growth rates correspond to better development (Supplementary Table S2). 430 
 20 
Analysis of the embryo growth rates demonstrated that the secretome of undifferentiated 431 
EnSCs compromised blastocyst development, exemplified by a growth score of 0 in 13 out of 432 
23 (57%) embryos. By contrast, only 3 out of 34 (9%) embryos had a growth score of 0 when 433 
cultured in supernatant from decidualizing EnSCs (Chi-square test: P < 0.005; Figure 5A). 434 
There was no statistical difference in the growth rates of human blastocysts cultured in the 435 
supernatant with the secretome of EnSC decidualized for either 2 or 8 days.  In addition, no 436 
significant differences were found in the growth rates between embryos cultured in medium 437 
conditioned by EnSC cultures from pregnant versus non-pregnant patients, whether 438 
decidualized or not (data not shown).  Finally, the embryonic response to secreted decidual 439 
factors was examined more closely by comparing the cytokine content of human blastocysts 440 
cultured in supernatant of EnSCs decidualized for either 2 or 8 days. Multiplex suspension 441 
bead immunoassay allowed quantification of 20 analytes in microdroplets of 18 embryos 442 
cultured in medium conditioned by early decidualizing cells (day 2) and 19 embryos cultured 443 
in supernatant of late decidualizing cells (day 8). Following hierarchical clustering, the 444 
dendrogram showed that the cytokine / chemokine profiles of embryos cultured in 445 
supernatant of EnSCs decidualized for 2 days were unrelated to either growth rate or clinical 446 
group, suggesting an embryo-specific response (Figure 5B). By contrast, the secretome 447 
profiles of embryos cultured in day 8 supernatant clustered, with the exception of one sample, 448 
with the clinical groups, indicating the lack of a significant embryonic secretory response 449 
(Figure 5C).  450 
 451 
 452 
  453 
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Discussion 454 
Aberrant decidual responses in purified primary EnSC cultures have been linked to a variety 455 
of reproductive disorders, including endometriosis (Aghajanova et al., 2010a, Aghajanova et 456 
al., 2010b, Klemmt et al., 2006, Velarde et al., 2009), polycystic ovary syndrome (Piltonen et 457 
al., 2015), and recurrent miscarriage (Salker et al., 2010, Salker et al., 2011, Salker et al., 458 
2012). These pioneering studies demonstrated that the responsiveness of EnSCs to steroid 459 
signals and other cues is not predetermined but occurs in a disease-specific manner. In this 460 
study, we examined if EnSCs contribute to failed implantation. Study subjects were recruited 461 
solely because of the need for ART, and irrespective of the cause of infertility or previous 462 
treatment cycles.  463 
We reasoned that a deficiency of endometrial MSCs could lead to aberrant EnSC function 464 
and implantation failure. While the overall CFU-F activity at passage 1 was comparable 465 
between the pregnant and non-pregnant group, three cultures associated with failed 466 
implantation were deficient in clonogenic MSCs. The secretome of these cultures was 467 
markedly divergent from other cultures. This observation supports our hypothesis that the 468 
abundance of endometrial stem cell populations is an important determinant of reproductive 469 
outcome, although further studies are needed. Overall, the induction of ‘classical’ decidual 470 
marker genes was not informative in terms of predicting reproductive success or failure, 471 
which was disappointing as the same markers have been widely used to determine the impact 472 
of reproductive disorders on the differentiation potential of EnSCs (Klemmt et al., 2006, 473 
Piltonen et al., 2015, Salker et al., 2010). However, the level of induction was highly variable 474 
between cultures, which probably reflects the clinical heterogeneity of the study population.  475 
For implantation to take place, differentiating EnSCs must transit through distinct functional 476 
phenotypes in response to elevated circulating progesterone levels and rising cellular cAMP 477 
levels (Gellersen and Brosens, 2014, Jones et al., 2006). This decidual transitional pathway is 478 
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characterized first by an acute auto-inflammatory phase, which is followed by a profound 479 
anti-inflammatory response. The initial auto-inflammatory response associated with decidual 480 
transformation of EnSCs renders the endometrium receptive to embryo implantation (Salker 481 
et al., 2012), whereas acquisition of a mature secretory phenotype enables the endometrium 482 
to respond to individual embryos in a manner that either supports further development or 483 
facilitates early rejection(Brosens et al. , 2014b). Secretome analysis demonstrated that 484 
EnSCs from the pregnant group closely phenocopied this transitional pathway in culture, 485 
exemplified by the marked and distinct secretory response on day 2 of decidualization. By 486 
contrast, this transitional pathway was clearly disordered in cultures from the failed 487 
implantation group. In addition, these cultures no longer exhibited temporal changes in the 488 
secretion of key factors involved in inflammation (IL-6), angiogenesis and 489 
lymphangiogenesis (VEGF-A, VEGF-D), endometrial receptivity and embryo development 490 
(LIF, BDNF) (Cha et al., 2012, Kawamura et al., 2009, Kim et al., 2014, Krussel et al , 2003, 491 
Stewart et al., 1992). 492 
Notably, the difference in secretome between the two groups of cultures was most 493 
pronounced in undifferentiated cells. CCL3, a potent inflammatory chemokine involved in 494 
innate immunity as well as wound repair (Chen et al., 2013, DiPietro et al., 1998), was most 495 
strongly associated with successful pregnancy, which emphasizes further the importance of 496 
transient endometrial inflammation for implantation. Upon decidual transformation, the 497 
secretory profiles in both the pregnant and non-pregnant group tended to converge, albeit 498 
with some notable exceptions. This is a potentially important observation for a number of 499 
reasons. First, it suggests that endometrial defects associated with reproductive failure could 500 
be more prominent in the proliferative phase of the cycle. Second, the convergence of 501 
secretomes, if recapitulated in vivo, suggests that delaying transfer by a few days could 502 
potentially be beneficial for women at risk of implantation failure. Finally, previous studies 503 
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reported that the decidual response in cultured EnSCs from recurrent miscarriage patients 504 
becomes increasingly divergent as the differentiation process unfolds (Salker et al., 2010, 505 
Salker et al., 2011, Salker et al., 2012), which indicates that different pathways are involved 506 
in failed implantation and early pregnancy loss.  507 
Analysis of human blastocysts indicates that the stromal microenvironment is a major 508 
determinant of embryo survival.  Our findings demonstrate that the secretome changes 509 
associated with undifferentiated EnSCs transitioning to fully decidualized cells induce a 510 
graded embryo response, ranging from embryonic growth arrest to a transient embryo-511 
specific secretory response and finally quiescence. Although the EnSC secretome was 512 
divergent between the pregnant and non-pregnant groups, no discernible difference in embryo 513 
response was observed. This may reflect that EnSC conditioned medium was pooled for the 514 
embryo experiments, that only a limited number of blastocysts were available for these 515 
experiments, or that the duration of incubation was too short. Another potential pitfall is that 516 
these experiments were performed ‘out-of-phase’ as there is no evidence that day 6 human 517 
embryos are already embedded in the decidualizing stroma. However, there is histological 518 
evidence of a Carnegie stage 5a human embryo (post-fertilization age of 7 to 8 days) 519 
surrounded by EnSCs. Thus, while our embryo experiments may indeed be ‘out-of-phase’, it 520 
is probably only by 1 or perhaps 2 days  (Gardner and Schoolcraft, 1999, Gardner DK, 1999). 521 
In summary, cyclic menstruation and renewal renders the endometrium intrinsically dynamic 522 
and arguably capable of adapting to ensure reproductive success (Gellersen and Brosens, 523 
2014, Lucas et al., 2013). It is evident that a community of resident cells, ranging from 524 
immature progenitor cells to mature and senescent cells, makes up the stromal compartment 525 
of the endometrium. It is conceivable that the constituents of this community fluctuate from 526 
cycle to cycle, with transient imbalances contributing to sporadic IVF failure. The impact of 527 
damaged or deficient progenitor populations is likely to be more severe and prolonged and 528 
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could account for RIF. Our finding that endometrial defects associated with implantation 529 
failure are present prior to ART has potentially important clinical ramifications as it raises the 530 
prospect that screening of the endometrium prior to ART could minimise the risk of 531 
subsequent treatment failure.  532 
 533 
  534 
 25 
Acknowledgement 535 
We are grateful to all the women who participated in this study. We also thank the staff at 536 
Nurture Fertility and Anne Skinner for assistance in processing the endometrial biopsies.  537 
 538 
Authors’ roles 539 
R.R.P.D., A.A., Y.H.L., Y.M., performed the experimental work. Y.H.L., J.K.Y.C., R.R.P.D., 540 
A.A., H.V.D.V, E.S.L. and J.J.B assisted in the analysis. L.P., M.N.B., and N.R-F. collected 541 
and processed the endometrial biopsies. A.A. and H.V.D.V. performed the human embryo 542 
experiments. Y.H.L performed the secretome analysis. J.J.B. designed the study and wrote 543 
the manuscript. Y.H.L., H.V.D.V, B.C., S.Q., J.K.Y.C. and N.R.-F. contributed to design of 544 
the study and all authors edited and approved the manuscript.  545 
 546 
Funding 547 
R.R.P.D., S.Q., and J.J.B are supported by the Biomedical Research Unit in Reproductive 548 
Health, a joint initiative of the University Hospitals Coventry & Warwickshire and Warwick 549 
Medical School. L.P. and M.N.B. were funded by the University of Nottingham and Nurture 550 
Fertility, and the National Medical Research Council, Singapore (NMRC/BNIG14NOV023). 551 
 552 
Conflict of interest 553 
The authors have declared that no conflict of interest exists. 554 
  555 
 26 
References 556 
 557 
1. Aghajanova L, Horcajadas JA, Weeks JL, Esteban FJ, Nezhat CN, Conti M, Giudice LC. The 558 
protein kinase A pathway-regulated transcriptome of endometrial stromal fibroblasts 559 
reveals compromised differentiation and persistent proliferative potential in 560 
endometriosis. Endocrinology 2010a;151:1341-1355. 561 
2. Aghajanova L, Tatsumi K, Horcajadas JA, Zamah AM, Esteban FJ, Herndon CN, Conti M, 562 
Giudice LC. Unique Transcriptome, Pathways, and Networks in the Human Endometrial 563 
Fibroblast Response to Progesterone in Endometriosis. Biology of Reproduction 564 
2011;84:801-815. 565 
3. Al-Sabbagh M, Lam EW, Brosens JJ. Mechanisms of endometrial progesterone resistance. 566 
Mol Cell Endocrinol 2012;358:208-215. 567 
4. Barragan F, Irwin JC, Balayan S, Erikson DW, Chen JC, Houshdaran S, Piltonen TT, Spitzer 568 
TL, George A, Rabban JT et al. Human Endometrial Fibroblasts Derived from 569 
Mesenchymal Progenitors Inherit Progesterone Resistance and Acquire an 570 
Inflammatory Phenotype in the Endometrial Niche in Endometriosis. Biology of 571 
reproduction 2016;94:118. 572 
5. Brosens JJ, Salker MS, Teklenburg G, Nautiyal J, Salter S, Lucas ES, Steel JH, Christian M, 573 
Chan YW, Boomsma CM et al. Uterine selection of human embryos at implantation. 574 
Scientific reports 2014a;4:3894. 575 
6. Brosens JJ, Salker MS, Teklenburg G, Nautiyal J, Salter S, Lucas ES, Steel JH, Christian M, 576 
Chan YW, Boomsma CM et al. Uterine selection of human embryos at implantation. Sci 577 
Rep 2014b;4:3894. 578 
7. Cervello I, Mas A, Gil-Sanchis C, Peris L, Faus A, Saunders PT, Critchley HO, Simon C. 579 
Reconstruction of endometrium from human endometrial side population cell lines. PloS 580 
one 2011;6:e21221. 581 
8. Cha J, Sun X, Dey SK. Mechanisms of implantation: strategies for successful pregnancy. 582 
Nature medicine 2012;18:1754-1767. 583 
9. Chen JC, Erikson DW, Piltonen TT, Meyer MR, Barragan F, McIntire RH, Tamaresis JS, Vo 584 
KC, Giudice LC, Irwin JC. Coculturing human endometrial epithelial cells and stromal 585 
fibroblasts alters cell-specific gene expression and cytokine production. Fertility and 586 
sterility 2013;100:1132-1143. 587 
 27 
10. Collins MK, Tay CS, Erlebacher A. Dendritic cell entrapment within the pregnant uterus 588 
inhibits immune surveillance of the maternal/fetal interface in mice. J Clin Invest 589 
2009;119:2062-2073. 590 
11. Cooke PS, Buchanan DL, Young P, Setiawan T, Brody J, Korach KS, Taylor J, Lubahn DB, 591 
Cunha GR. Stromal estrogen receptors mediate mitogenic effects of estradiol on uterine 592 
epithelium. Proc Natl Acad Sci U S A 1997;94:6535-6540. 593 
12. Diaz-Gimeno P, Horcajadas JA, Martinez-Conejero JA, Esteban FJ, Alama P, Pellicer A, 594 
Simon C. A genomic diagnostic tool for human endometrial receptivity based on the 595 
transcriptomic signature. Fertility and sterility 2011;95:50-60, 60.e51-15. 596 
13. DiPietro LA, Burdick M, Low QE, Kunkel SL, Strieter RM. MIP-1alpha as a critical 597 
macrophage chemoattractant in murine wound repair. J Clin Invest 1998;101:1693-598 
1698. 599 
14. Fulton RJ, McDade RL, Smith PL, Kienker LJ, Kettman JR, Jr. Advanced multiplexed 600 
analysis with the FlowMetrix system. Clin Chem 1997;43:1749-1756. 601 
15. Gardner DK, Schoolcraft WB. Culture and transfer of human blastocysts. Current opinion 602 
in obstetrics & gynecology 1999;11:307-311. 603 
16. Gardner DK SW. In vitro culture of human blastocyst. In In Jansen R MD (ed) Towards 604 
Reproductive Certainty: Infertility and Genetics Beyond. 1999. Parthenon Press, 605 
Carnforth, pp. 378–388. 606 
17. Gargett CE, Nguyen HP, Ye L. Endometrial regeneration and endometrial 607 
stem/progenitor cells. Rev Endocr Metab Disord 2012;13:235-251. 608 
18. Gargett CE, Schwab KE, Deane JA. Endometrial stem/progenitor cells: the first 10 years. 609 
Human reproduction update 2016;22:137-163. 610 
19. Gellersen B, Brosens JJ. Cyclic decidualization of the human endometrium in 611 
reproductive health and failure. Endocrine reviews 2014;35:851-905. 612 
20. Gottschalk PG, Dunn JR. The five-parameter logistic: a characterization and comparison 613 
with the four-parameter logistic. Anal Biochem 2005;343:54-65. 614 
21. Jones MC, Fusi L, Higham JH, Abdel-Hafiz H, Horwitz KB, Lam EW, Brosens JJ. Regulation 615 
of the SUMO pathway sensitizes differentiating human endometrial stromal cells to 616 
progesterone. Proc Natl Acad Sci U S A 2006;103:16272-16277. 617 
22. Kawamura K, Kawamura N, Sato W, Fukuda J, Kumagai J, Tanaka T. Brain-derived 618 
neurotrophic factor promotes implantation and subsequent placental development by 619 
stimulating trophoblast cell growth and survival. Endocrinology 2009;150:3774-3782. 620 
23. Kim JH, Lee HJ, Yu EJ, Jee BC, Suh CS, Kim SH. Dose-dependent embryotrophic effect of 621 
recombinant granulocyte-macrophage colony-stimulating factor and brain-derived 622 
 28 
neurotrophic factor in culture medium for mouse preimplantation embryo. Obstet 623 
Gynecol Sci 2014;57:373-378. 624 
24. Klemmt PA, Carver JG, Kennedy SH, Koninckx PR, Mardon HJ. Stromal cells from 625 
endometriotic lesions and endometrium from women with endometriosis have reduced 626 
decidualization capacity. Fertility and sterility 2006;85:564-572. 627 
25. Koler M, Achache H, Tsafrir A, Smith Y, Revel A, Reich R. Disrupted gene pattern in 628 
patients with repeated in vitro fertilization (IVF) failure. Human reproduction (Oxford, 629 
England) 2009;24:2541-2548. 630 
26. Koot YE, van Hooff SR, Boomsma CM, van Leenen D, Groot Koerkamp MJ, Goddijn M, 631 
Eijkemans MJ, Fauser BC, Holstege FC, Macklon NS. An endometrial gene expression 632 
signature accurately predicts recurrent implantation failure after IVF. Scientific reports 633 
2016;6:19411. 634 
27. Krussel JS, Bielfeld P, Polan ML, Simon C. Regulation of embryonic implantation. Eur J 635 
Obstet Gynecol Reprod Biol 2003;110 Suppl 1:S2-9. 636 
28. Li Q, Kannan A, DeMayo FJ, Lydon JP, Cooke PS, Yamagishi H, Srivastava D, Bagchi MK, 637 
Bagchi IC. The antiproliferative action of progesterone in uterine epithelium is mediated 638 
by Hand2. Science 2011;331:912-916. 639 
29. Lucas ES, Dyer NP, Murakami K, Lee YH, Chan YW, Grimaldi G, Muter J, Brighton PJ, 640 
Moore JD, Patel G et al. Loss of Endometrial Plasticity in Recurrent Pregnancy Loss. Stem 641 
cells (Dayton, Ohio) 2016;34:346-356. 642 
30. Lucas ES, Salker MS, Brosens JJ. Uterine plasticity and reproductive fitness. Reproductive 643 
biomedicine online 2013;27:506-514. 644 
31. Macklon NS, Brosens JJ. The human endometrium as a sensor of embryo quality. Biology 645 
of reproduction 2014;91:98. 646 
32. Murakami K, Bhandari H, Lucas ES, Takeda S, Gargett CE, Quenby S, Brosens JJ, Tan BK. 647 
Deficiency in clonogenic endometrial mesenchymal stem cells in obese women with 648 
reproductive failure--a pilot study. PloS one 2013;8:e82582. 649 
33. Murakami K, Lee YH, Lucas ES, Chan YW, Durairaj RP, Takeda S, Moore JD, Tan BK, 650 
Quenby S, Chan JK et al. Decidualization induces a secretome switch in perivascular 651 
niche cells of the human endometrium. Endocrinology 2014;155:4542-4553. 652 
34. Nancy P, Tagliani E, Tay CS, Asp P, Levy DE, Erlebacher A. Chemokine gene silencing in 653 
decidual stromal cells limits T cell access to the maternal-fetal interface. Science 654 
2012;336:1317-1321. 655 
35. Piltonen TT, Chen JC, Khatun M, Kangasniemi M, Liakka A, Spitzer T, Tran N, Huddleston 656 
H, Irwin JC, Giudice LC. Endometrial stromal fibroblasts from women with polycystic 657 
ovary syndrome have impaired progesterone-mediated decidualization, aberrant 658 
 29 
cytokine profiles and promote enhanced immune cell migration in vitro. Human 659 
Reproduction 2015;30:1203-1215. 660 
36. Salker M, Teklenburg G, Molokhia M, Lavery S, Trew G, Aojanepong T, Mardon HJ, 661 
Lokugamage AU, Rai R, Landles C et al. Natural selection of human embryos: impaired 662 
decidualization of the endometrium disables embryo-maternal interactieons and causes 663 
recurrent pregnant loss. PLoS One 2010;April 22. 664 
37. Salker MS, Christian M, Steel JH, Nautiyal J, Lavery S, Trew G, Webster Z, Al-Sabbagh M, 665 
Puchchakayala G, Foller M et al. Deregulation of the serum- and glucocorticoid-inducible 666 
kinase SGK1 in the endometrium causes reproductive failure. Nature medicine 667 
2011;17:1509-1513. 668 
38. Salker MS, Nautiyal J, Steel JH, Webster Z, Sucurovic S, Nicou M, Singh Y, Lucas ES, 669 
Murakami K, Chan YW et al. Disordered IL-33/ST2 activation in decidualizing stromal 670 
cells prolongs uterine receptivity in women with recurrent pregnancy loss. PloS one 671 
2012;7:e52252. 672 
39. Sherwin JR, Hastings JM, Jackson KS, Mavrogianis PA, Sharkey AM, Fazleabas AT. The 673 
endometrial response to chorionic gonadotropin is blunted in a baboon model of 674 
endometriosis. Endocrinology 2010;151:4982-4993. 675 
40. Stewart CL, Kaspar P, Brunet LJ, Bhatt H, Gadi I, Kontgen F, Abbondanzo SJ. Blastocyst 676 
implantation depends on maternal expression of leukaemia inhibitory factor. Nature 677 
1992;359:76-79. 678 
41. Teklenburg G, Salker M, Molokhia M, Lavery S, Trew G, Aojanepong T, Mardon HJ, 679 
Lokugamage AU, Rai R, Landles C et al. Natural selection of human embryos: 680 
decidualizing endometrial stromal cells serve as sensors of embryo quality upon 681 
implantation. PloS one 2010;5:e10258. 682 
42. Velarde MC, Aghajanova L, Nezhat CR, Giudice LC. Increased mitogen-activated protein 683 
kinase kinase/extracellularly regulated kinase activity in human endometrial stromal 684 
fibroblasts of women with endometriosis reduces 3',5'-cyclic adenosine 5'-685 
monophosphate inhibition of cyclin D1. Endocrinology 2009;150:4701-4712. 686 
43. Wang X, Matsumoto H, Zhao X, Das SK, Paria BC. Embryonic signals direct the formation 687 
of tight junctional permeability barrier in the decidualizing stroma during embryo 688 
implantation. Journal of cell science 2004;117:53-62. 689 
44. Weimar CH, Macklon NS, Post Uiterweer ED, Brosens JJ, Gellersen B. The motile and 690 
invasive capacity of human endometrial stromal cells: implications for normal and 691 
impaired reproductive function. Human reproduction update 2013;19:542-557. 692 
  693 
 30 
Figure Legends 694 
 695 
Figure 1. Abundance of clonogenic cells in primary endometrial stromal cell cultures 696 
prior to successful (pregnant) or failed embryo implantation (non-pregnant) after ART 697 
in women. 698 
(A) representative images of clones obtained after subjecting primary endometrial stromal 699 
cells (EnSCs) to colony-forming assays. (B) colonies with > 50 cells were counted and cloning 700 
efficiency (CE) calculated. Triangles in the failed implantation group indicate primary EnSC 701 
cultures deficient in clonogenic mesenchymal stem cells (MSCs), defined by CE of  1%. 702 
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Figure 2. Induction of decidual marker genes.  717 
EnSCs from the pregnant and non-pregnant group (n = 10 in each group) were subjected to 718 
decidualization for the indicated time-points. Total RNA was then extracted and subjected to 719 
RT-qPCR analysis. PRL (prolactin), IGFBP1 (insulin-like growth factor binding protein 1) 720 
and HSD11B1 (11β-hydroxysteroid dehydrogenase 1) transcript levels were normalized 721 
against the levels of L19 and expressed in arbitrary units (A.U.). The induction of decidual 722 
marker genes was comparable between the two groups at each time-point (P > 0.05; Mann–723 
Whitney U test). Note the logarithmic Y-axis. NP/Low CFU (non-pregnant / low colony-724 
forming unit) denotes cultures from the non-pregnant group with MSC deficiency.  725 
 726 
 727 
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 729 
 730 
 731 
 732 
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735 
Figure 3. Divergent human EnSC secretome prior to successful or failed implantation. 736 
(A) Hierarchical clustering using Euclidean distance of factors that were differentially secreted 737 
upon decidualization of EnSCs associated with successful implantation. (B) The same 738 
analysis was performed on decidualizing cultures from the non-pregnant group. The 739 
bifurcation in the dendrogram above the heatmap in the pregnant group indicates that the 740 
secretory response in decidualizing EnSCs is most distinct after 2 days of differentiation. 741 
By contrast, the temporal secretome changes in cultures associated with implantation 742 
failure (non-pregnant) were both qualitatively different and disordered. The colour keys 743 
are depicted on the right of the heatmaps (blue: decreased expression; yellow: increased 744 
expression)  745 
 746 
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 755 
Figure 4. Two-dimensional partial least squares loading plots of undifferentiated and 756 
decidualized secretomes in primary EnSC cultures from pregnant and non-pregnant 757 
patients.  758 
Partial least squares (PLS) regression analysis was used to evaluate the temporal multivariate 759 
differences in cytokine and immune-modulatory secretome profile as a result of implantation. 760 
The analysis showed that the secretome profiles are less divergent in implantation-positive 761 
cultures, at least in undifferentiated cells and cells decidualized for 8 days. Furthermore, the 762 
differences in secretomes were most pronounced in undifferentiated cells. Decidualization 763 
leads to convergence of secretomes, although not in MSC-deficient cultures (blue triangles). 764 
The X-axis represents principal component 1, and the Y-axis principal component 2. NP/Low 765 
CFU refers to cultures from the non-pregnant group with MSC deficiency.  766 
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 775 
Figure 5. Impact of EnSC secretome on human blastocysts.  776 
A, growth rates (scored 0, 1, and 2) of human blastocysts cultured in conditioned medium 777 
from undifferentiated (n = 24) and decidualizing EnSCs (day 2 and day 8) (n = 33). *** 778 
indicates P < 0.005 (Chi-square test). B, Hierarchical clustering using Euclidean distance of 779 
20 cytokines and chemokines measured in microdroplets of human blastocysts cultured in 780 
conditioned medium of EnSC decidualized for 2 days. P: pregnant, NP: non-pregnant, GR: 781 
growth rate. C, Hierarchical clustering using Euclidean distance of 20 cytokines measured in 782 
microdroplets of human blastocysts cultured in conditioned medium of EnSC decidualized 783 
for 8 days. The colour keys are depicted on the right of the heatmaps (green: decreased 784 
expression; red: increased expression)  785 
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Supplementary Figure S1. Factors secreted by undifferentiated EnSCs associated 797 
with successful implantation 798 
Regression coefficient analysis was used to identify which secreted factors were most 799 
closely associated with successful implantation in undifferentiated EnSCs. Out of 23 800 
detectable factors, CCL3 exhibited the highest regression coefficient value in 801 
undifferentiated cultures, indicating a strong positive association with implantation. 802 
Supplementary Figure S2. Factors secreted by decidualizing EnSCs associated with 803 
successful implantation 804 
Regression coefficient analysis of decidualizing cultures (day 2 or day 8) of the pregnant 805 
group demonstrated that the strength of the association of CCL3 and successful 806 
implantation diminishes upon differentiation of EnSCs. In decidualizing cells, a positive 807 
factor (IL-6) and several negative factors (CCL11, CCL5, IL-18, EGF and VEGF-D), all 808 
with a regression coefficient of < 0.2, were associated with successful implantation. 809 
 810 
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Fig. S1. Regression coefficient analysis was used to identify which secreted factors were most 
closely associated with successful implantation in undifferentiated EnSCs. Out of 23 
detectable factors, CCL3 exhibited the highest regression coefficient value in undifferentiated 
cultures, indicating a strong positive association with implantation. 
  
  
 
Fig. S2. Regression coefficient analysis of decidualizing cultures (day 2 or day 8) of the 
pregnant group demonstrated that the strength of the association of CCL3 and successful 
implantation diminishes upon differentiation of EnSCs. In decidualizing cells, a positive 
factor (IL-6) and several negative factors (CCL11, CCL5, IL-18, EGF and VEGF-D), all with 
a regression coefficient of < 0.2, were associated with successful implantation. 
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Supplementary Tables 
 
 
Table S1: Demographic and treatment details of the study population 
*There were no significant difference (P > 0.05) in patient or treatment characteristics.  
3 
Table S2: Morphology scores and growth rates of human embryos cultured in EnSC 
conditioned medium. 
EnSC Pregnant Morphology  
score post  
warming 
Growth rate  
after 24h of  
culture 
        
Undifferentiated Yes BL2 0 
Undifferentiated Yes BL3BA 0 
Undifferentiated Yes BL3CB 0 
Undifferentiated Yes BL3CA 1 
Undifferentiated Yes BL2 1 
Undifferentiated Yes BL4AA 2 
Undifferentiated Yes BL3BA 2 
Undifferentiated Yes BL3BB 0 
Undifferentiated Yes BL3BC 0 
Undifferentiated Yes BL4CB 0 
Undifferentiated Yes Collaps 0 
Undifferentiated No BL3BA 1 
Undifferentiated No BL2 0 
Undifferentiated No BL3AB 2 
Undifferentiated No BL8 2 
Undifferentiated No BL3BB 0 
Undifferentiated No BL2 0 
Undifferentiated No BL4BA 1 
Undifferentiated No BL3BB 1 
Undifferentiated No BL3BB 0 
Undifferentiated No BL2 0 
Undifferentiated No BL4CB 0 
Undifferentiated No BL3CB 1 
Decidualized (D2) Yes BL3BB 2 
Decidualized (D2) Yes BL4CB 1 
Decidualized (D2) Yes BL3CB 2 
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Decidualized (D2) Yes BL4BB 2 
Decidualized (D2) Yes BL3CB 2 
Decidualized (D2) Yes BLBCB 2 
Decidualized (D2) No BL4CB 1 
Decidualized (D2) No BL4BB 1 
Decidualized (D2) No BL3AA 1 
Decidualized (D2) No BL3BB 1 
Decidualized (D2) No BL4BB 2 
Decidualized (D2) No BL3BC 0 
Decidualized (D2) No BL2 2 
Decidualized (D2) No BL3AA 2 
Decidualized (D2) No BL3AA 2 
Decidualized (D2) No BL3BB 1 
Decidualized (D8) Yes BL3BA 2 
Decidualized (D8) Yes BL3CB 2 
Decidualized (D8) Yes BL3BB 1 
Decidualized (D8) Yes BL3BA 1 
Decidualized (D8) Yes BL3CC 2 
Decidualized (D8) Yes BL8 1 
Decidualized (D8) Yes BL2 1 
Decidualized (D8) No BL3BB 0 
Decidualized (D8) No BL3BA 2 
Decidualized (D8) No BL3AA 2 
Decidualized (D8) No BL3CB 2 
Decidualized (D8) No BL3CC 1 
Decidualized (D8) No BL3BB 2 
Decidualized (D8) No BL3BB 2 
Decidualized (D8) No BL4BB 2 
Decidualized (D8) No BL3AC 0 
Decidualized (D8) No BL4BB 2 
Decidualized (D8) No BL4CB 2 
Embryos were scored on morphology post warming using the Gardner and Schoolcraft 
criteria41,42. After culture of 24 hours in EnSC supernatant, embryos were morphologically 
evaluated and scored with growth rates 0, 1 or 2 to indicate development based on expansion and 
morphology 
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scores of ICM and TE: 0: embryo was degraded or did not develop further; 1: embryo 
moderately expanded or significantly expanded further accompanied with a “C”-score for the 
TE and/or ICM; 2: embryos significantly expanded with ≥ “B”-score for the TE and/or ICM 
 
Supplementary Table S3: Secreted cytokines, chemokines and growth factors analysed 
by multiplex suspension bead immunoassay 
BDNF: Brain-derived neurotrophic factor 
EGF: Epidermal growth factor 
CCL11 (Eotaxin): C-C motif chemokine 11 
FGF-2 (FGF basic): Basic fibroblast growth 
factor 
GM-CSF: Granulocyte macrophage colony-
stimulating factor 
CXCL1 (GROα): Chemokine (C-X-C 
motif) ligand 1; Growth regulated 
oncogene-alpha 
HGF: Hepatocyte growth factor 
IFNγ: Interferon gamma 
IFNα: Interferon alpha 
IL-1RA: Interleukin-1 receptor alpha 
IL-1β: Interleukin-1 beta 
IL-1α: Interleukin-1 alpha 
IL-2: Interleukin-2 
IL-4: Interleukin-4 
IL-5: Interleukin-5  
IL-6: Interleukin-6 
IL-7: Interleukin-7 
CXCL8 (IL-8): Chemokine (C-X-C motif) 
ligand 8; Interleukin-8 
IL-9: Interleukin-9 
IL-10: Interleukin-10 
IL-12 p70: Interleukin-12 heterodimer 
IL-13: Interleukin-13 
IL-15: Interleukin-15 
IL-17A: Interleukin-17A 
IL-18: Interleukin-18 
IL-21: Interleukin-21  
IL-22: Interleukin-22 
 
IL-23: Interleukin-23 
IL-27: Interleukin-27 
IL-31: Interleukin-31 
CXCL10 (IP-10): C-X-C motif chemokine 
10; Interferon gamma-induced protein 10 
LIF: Leukemia inhibitory factor 
CCL2 (MCP-1): Chemokine (C-C motif) 
ligand 2; Monocyte chemotactic protein 1  
CCL3 (MIP-1α): Chemokine (C-C motif) 
ligand 3; Macrophage inflammatory protein 
1-alpha 
CCL4 (MIP-1β): Chemokine (C-C motif) 
ligand 4; Macrophage inflammatory protein 
1-beta 
βNGF: Beta nerve growth factor 
PDGF-BB: Platelet-Derived Growth Factor-
BB 
PLGF: Placental growth factor 
CCL5 (RANTES): Chemokine (C-C motif) 
ligand 5 
SCF: Stem cell factor 
CXCL12 (SDF1α): C-X-C motif chemokine 
12; stromal cell-derived factor alpha 
TNFα: Tumor necrosis factor alpha 
LTA (TNFβ): Lymphotoxin-alpha; tumor 
necrosis factor-beta 
VEGF-A: Vascular endothelial growth 
factor A 
VEGF-D: Vascular endothelial growth 
factor D 
Factors that are underlined were undetectable in > 50% of samples and therefore excluded 
from subsequent analyses. 
 
